Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS)

23 filings reported holding PHVS - Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share as of Q1 2022.
Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 21,685,388 shares of 62,254,300 outstanding shares and own 35% of the company stock.
Largest 10 shareholders include FMR LLC (3,315,188 shares), Foresite Capital Management IV, LLC (3,261,926 shares), Bain Capital Life Sciences Investors, LLC (3,180,601 shares), VIKING GLOBAL INVESTORS LP (2,480,319 shares), GENERAL ATLANTIC, L.P. (2,420,155 shares), venBio Partners LLC (2,303,310 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1,577,078 shares), SUVRETTA CAPITAL MANAGEMENT, LLC (827,540 shares), Cormorant Asset Management, LP (684,888 shares), and PICTET ASSET MANAGEMENT SA (537,630 shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.